Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Securities and Exchange Commission v. One or More Unknown Traders in the Securities of Bioverativ, Inc.
Case Number:
1:18-cv-00701
Court:
Nature of Suit:
Judge:
Government Agencies
-
December 03, 2020
SEC Nets $9.8M From AWOL Sanofi Insider Trading Suspect
A New York federal judge ruled Wednesday that a Swiss businessman ignoring civil and criminal cases accusing him of engaging in insider trading ahead of Sanofi SA's acquisition of Bioverativ Inc. owes the U.S. Securities and Exchange Commission $9.8 million, down from the requested $14.8 million.
-
November 10, 2020
SEC Wants $15M From Sanofi Insider Trading Suspect
The U.S. Securities and Exchange Commission is seeking $14.8 million from a Swiss businessman who has ignored civil and criminal lawsuits accusing him of engaging in insider trading ahead of Sanofi SA's acquisition of Bioverativ Inc.
-
June 13, 2019
Man Charged With $4.7M Sanofi Insider Trading Scheme
A Swiss businessman has been charged in the U.S. with insider trading ahead of Sanofi SA's acquisition of Bioverativ Inc. last year in an alleged get-rich-quick scheme that netted cash and stock options worth $4.7 million, prosecutors announced on Thursday.